Technology Commercialization Office

Showing 76 result(s) for "Life Sciences"



The Need The most abundant neurotransmitter in the central nervous system is glutamate. The role of this neurotransmitter is to send excitiatory signals to aid in modulation of normal brain function. However, abnormal release of glutamate can overstimulate the neuronal system, resulting in excitoxicty. Glutamate-mediated excitoxicity is involved in many neurological disorders, such as epilepsy, stroke, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Currently available drugs for the prevention of

Novel strategy to improve efficiency and specificity of tumor treatment via combinative use of a split & splice protein toxin and oncolytic virus.

A device to discourage IV-drug-abusing patients from self-accessing their IV ports while in the hospital

A novel method to increase vaccine effectiveness for TB

A bioreactor that facilitates rapid and automatic (or semiautomatic) monitoring and measuring of rare biological and metabolic events.

Prognostic Indications of Canine Lymphoid Neoplasia using plasma DNA assays.

Realistic immunohistochemical stained tissue section databases for training, certification, and machine standards.

A non-invasive and automated tumor budding image analysis system for colorectal cancer. This program can detect tumor buds in traditional H&E stained sections without the need for manual assessment.

A mechanism by which the inhibiting efects of drugs and other molecules on protein-protein interactions can be measured.

A novel therapeutic strategy to sensitize Hepatocellular Carcinoma tumors to a multikinase inhibitor for advanced stage treatment.